290
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Epoetin theta: efficacy and safety of IV administration in anaemic haemodialysis patients in the maintenance phase in comparison to epoetin beta

, , , , , & show all
Pages 2393-2402 | Accepted 23 Jul 2010, Published online: 02 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Abdulaziz Mohammed, Alaa Bagalagel, Karen MacDonald & Ivo Abraham. (2013) Clinical efficacy and safety of XM01, a biosimilar recombinant human erythropoietin, in the management of anemia. Biosimilars 3, pages 45-53.
Read now
Ivo Abraham & Karen MacDonald. (2012) Clinical safety of biosimilar recombinant human erythropoietins. Expert Opinion on Drug Safety 11:5, pages 819-840.
Read now
B. Gertz, P. Kes, A. Essaian, P. Bias, A. Buchner & D. Zellner. (2012) Epoetin theta: efficacy and safety of subcutaneous administration in anemic pre-dialysis patients in the maintenance phase in comparison to epoetin beta. Current Medical Research and Opinion 28:7, pages 1101-1110.
Read now

Articles from other publishers (6)

Edmund YM Chung, Suetonia C Palmer, Valeria M Saglimbene, Jonathan C Craig, Marcello Tonelli & Giovanni FM Strippoli. (2023) Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:2.
Crossref
Marianne Heibert Arnlind, Linda Fryklund, Sigurd Vitols & Göran Bertilsson. (2016) Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies—a systematic review. European Journal of Clinical Pharmacology 72:10, pages 1161-1169.
Crossref
Pere Gascon. (2015) The evolving role of biosimilars in haematology–oncology: a practical perspective. Therapeutic Advances in Hematology 6:6, pages 267-281.
Crossref
Suetonia C Palmer, Valeria Saglimbene, Dimitris Mavridis, Georgia Salanti, Jonathan C Craig, Marcello Tonelli, Natasha Wiebe & Giovanni FM Strippoli. (2014) Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Ivo Abraham, Lucy Han, Diana Sun, Karen MacDonald & Matti Aapro. (2014) Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: a simulation for the EU G5 countries. Future Oncology 10:9, pages 1599-1609.
Crossref
Judith Genevieve Marin, Marianna Leung, Clifford Lo, Nicole W Tsao & Daniel J Martinusen. (2014) Efficacy and Safety Data of Subsequent Entry Biologics Pertinent to Nephrology Practice: A Systematic Review. Canadian Journal of Kidney Health and Disease 1, pages 34.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.